Exhibit 31.1


                                  CERTIFICATION

I, Gary A. Shangold, M.D., certify that:


1.   I have  reviewed  this  quarterly  report on Form 10-QSB of NovaDel  Pharma
     Inc.;

2.   Based on my knowledge,  this  quarterly  report does not contain any untrue
     statement of a material fact or omit to state a material fact  necessary to
     make the statements  made, in light of the  circumstances  under which such
     statements  were made, not misleading with respect to the period covered by
     this report;

3.   Based on my  knowledge,  the  financial  statements,  and  other  financial
     information  included  in  this  report,  fairly  present  in all  material
     respects the financial  condition,  results of operations and cash flows of
     the small  business  issuer as of, and for,  the periods  presented in this
     report;

4.   The small business issuer's other certifying  officer and I are responsible
     for  establishing  and maintaining  disclosure  controls and procedures (as
     defined  in  Exchange  Act Rules  13a-15(e)  and  15d-15(e)  [intentionally
     omitted] for the registrant and we have:

     a)   Designed  such  disclosure  controls  and  procedures,  or caused such
          disclosure   controls  and   procedures  to  be  designed   under  our
          supervision, to ensure that material information relating to the small
          business  issuer,  including its  consolidated  subsidiaries,  is made
          known to us by others within those entities,  particularly  during the
          period in which this report is being prepared;

     b)   [intentionally omitted]

     c)   Evaluated the effectiveness of the small business issuer's  disclosure
          controls and procedures;  and presented in this report our conclusions
          about the effectiveness of the disclosure controls and procedures,  as
          of the  end of the  period  covered  by  this  report  based  on  such
          evaluation; and

     d)   Disclosed  in this  report any change in the small  business  issuer's
          internal  control over financial  reporting  that occurred  during the
          small business issuer's most recent fiscal quarter (the small business
          issuer's  fourth fiscal  quarter in the case of an annual report) that
          has materially affected, or is reasonably likely to materially affect,
          the small business issuer's internal control over financial reporting;
          and

5.   The small business issuer's other certifying  officer and I have disclosed,
     based on our most recent  evaluation  of internal  control  over  financial
     reporting to the small business  issuer's  auditors and the audit committee
     of small business  issuer's  board of directors (or persons  performing the
     equivalent function):

     a)   All  significant  deficiencies  in the design or operation of internal
          controls  over  financial  reporting  which are  reasonable  likely to
          adversely  affect  the small  business  issuer's  ability  to  record,
          process, summarize and report financial data information and

     b)   Any fraud, whether or not material,  that involves management or other
          employees who have a significant  role in the small business  issuer's
          internal controls over financial reporting.


Date:  March 16, 2004                        Gary A. Shangold, M.D.
                                             President & Chief Executive Officer

                                             /s/ Gary A. Shangold, M.D.
                                             --------------------------
                                             (Signature)




                                       15